Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103.
Publication
, Conference
Wilson, WH; Porcu, P; Hurd, D; Martin, SE; Czuczman, M; Niedzwiecki, D; Saint Louis, JD; Johnson, JL; Cheson, B; Canellos, GP; Zelenetz, AD
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 1, 2005
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 1, 2005
Volume
23
Issue
16
Start / End Page
567S / 567S
Location
Orlando, FL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
41st Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wilson, W. H., Porcu, P., Hurd, D., Martin, S. E., Czuczman, M., Niedzwiecki, D., … Zelenetz, A. D. (2005). Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 23, pp. 567S-567S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Wilson, W. H., P. Porcu, D. Hurd, S. E. Martin, M. Czuczman, D. Niedzwiecki, J. D. Saint Louis, et al. “Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103.” In JOURNAL OF CLINICAL ONCOLOGY, 23:567S-567S. AMER SOC CLINICAL ONCOLOGY, 2005.
Wilson WH, Porcu P, Hurd D, Martin SE, Czuczman M, Niedzwiecki D, et al. Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 567S-567S.
Wilson, W. H., et al. “Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103.” JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 16, AMER SOC CLINICAL ONCOLOGY, 2005, pp. 567S-567S.
Wilson WH, Porcu P, Hurd D, Martin SE, Czuczman M, Niedzwiecki D, Saint Louis JD, Johnson JL, Cheson B, Canellos GP, Zelenetz AD. Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 567S-567S.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 1, 2005
Volume
23
Issue
16
Start / End Page
567S / 567S
Location
Orlando, FL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
41st Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences